Diagnosed arthritis afflicts 22 percent of the U.S. population and is projected to affect as many as 50 percent by 2030. Firstborn baby boomers recently reached 60, and the rest will do so over the next 15 years, creating the largest senior citizen demographic in history, as well as one of the biggest disease indication growth markets.

The BioWorld Arthritis Report 2009: Drug and Med-Tech Innovation and Economics report delivers comprehensive data and strong analysis on the arthritis phenomenon, which is poised to become a global burden on the health care system, payers and the population. BioWorld also details the promising prospects for investors in the field and provides a practical assessment of the R&D landscape.

Order the BioWorld Arthritis Report 2009: Drug and Med-Tech Innovation and Economics risk-free for 30 days for only $599 (plus $17.95 S&H). Call 1-800-688-2421 or 1-404-262-5476 and mention priority code S08443.